Integrin regulation of JNK signaling is complex; JNK has been shown to be either activated by β1 or αv integrins in head and neck [4] and in nasopharyngeal cancer [5] or suppressed by β1 integrins in prostate cancer as reported in our in vivo study [3]. The gene discussed is MAPK8; the disease is prostate carcinoma.